AAAAAA
Results: 1-25/30
Authors:
Stewart, WC
Day, DG
Holmes, KT
Stewart, JA
Citation: Wc. Stewart et al., Effect of timolol 0.5% gel and solution on pulmonary function in older glaucoma patients, J GLAUCOMA, 10(3), 2001, pp. 227-232
Authors:
Konstas, AGP
Lake, S
Maltezos, AC
Holmes, KT
Stewart, WC
Citation: Agp. Konstas et al., Twenty-four hour intraocular pressure reduction with latanoprost compared with pilocarpine third-line therapy in exfoliation glaucoma, EYE, 15, 2001, pp. 59-62
Authors:
DuBiner, H
Cooke, D
Dirks, M
Stewart, WC
VanDenburgh, AM
Felix, C
Citation: H. Dubiner et al., Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: A 30-day comparison with latanoprost, SURV OPHTHA, 45, 2001, pp. S353-S360
Authors:
Stewart, WC
Citation: Wc. Stewart, Additive efficacy of unoprostone isopropyl 0.12% (Rescula) to latanoprost 0.005% - Reply, AM J OPHTH, 132(3), 2001, pp. 448-449
Authors:
Stewart, WC
Citation: Wc. Stewart, Additive efficacy of unoprostone isopropyl 0.12% (Rescula) to latanoprost 0.005% - Reply, AM J OPHTH, 132(3), 2001, pp. 450-451
Authors:
Konstas, AGP
Stewart, WC
Topouzis, F
Tersis, I
Holmes, KT
Stangos, NT
Citation: Agp. Konstas et al., Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma, AM J OPHTH, 131(6), 2001, pp. 729-733
Authors:
Stewart, WC
Holmes, KT
Johnson, MA
Citation: Wc. Stewart et al., Washout periods for brimonidine 0.2% and latanoprost 0.005%, AM J OPHTH, 131(6), 2001, pp. 798-799
Authors:
Stewart, WC
Day, DG
Stewart, JA
Schuhr, J
Latham, KE
Citation: Wc. Stewart et al., The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension, AM J OPHTH, 131(5), 2001, pp. 631-635
Authors:
Stewart, WC
Sharpe, ED
Stewart, JA
Holmes, KT
Latham, KE
Citation: Wc. Stewart et al., Additive efficacy of unoprostone isopropyl 0.12% (Rescula) to latanoprost 0.005%, AM J OPHTH, 131(3), 2001, pp. 339-344
Authors:
Stewart, WC
Day, DG
Stewart, JA
Holmes, KT
Leech, JN
Rowan, CT
Schwartz, GF
Citation: Wc. Stewart et al., Therapeutic success of latanoprost 0.005% compared to brimonidine 0.2% in patients with open-angle glaucoma or ocular hypertension, J OCUL PH T, 16(6), 2000, pp. 557-564
Authors:
Stewart, WC
Sharpe, ED
Day, DG
Kolker, AE
Konstas, AGP
Lee, WH
Rieser, JC
Chopra, H
Holmes, KT
Citation: Wc. Stewart et al., Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension, J OCUL PH T, 16(3), 2000, pp. 251-259
Authors:
Konstas, AGP
Maltezos, A
Bufidis, T
Hudgins, AG
Stewart, WC
Citation: Agp. Konstas et al., Twenty-four hour control of intraocular pressure with dorzolamide and timolol maleate in exfoliation and primary open-angle glaucoma, EYE, 14, 2000, pp. 73-77
Authors:
Stewart, WC
Stewart, JA
Holmes, KT
Leech, JN
Citation: Wc. Stewart et al., Differences in ocular surface irritation between timolol hemihydrate and timolol maleate, AM J OPHTH, 130(6), 2000, pp. 712-716
Authors:
Lee, DA
Fechtner, RD
Fiscella, RG
Singh, K
Stewart, WC
Citation: Da. Lee et al., Emerging perspectives on glaucoma: Highlights oil a roundtable discussion, AM J OPHTH, 130(4), 2000, pp. S1-S11
Authors:
Stewart, WC
Kolker, AE
Sharpe, ED
Day, DG
Holmes, KT
Leech, JN
Johnson, M
Cantrell, JB
Citation: Wc. Stewart et al., Factors associated with long-term progression or stability in primary open-angle glaucoma, AM J OPHTH, 130(3), 2000, pp. 274-279
Authors:
Stewart, WC
Sharpe, ED
Harbin, TS
Pastor, SA
Day, DG
Holmes, KT
Stewart, JA
Citation: Wc. Stewart et al., Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure, AM J OPHTH, 129(6), 2000, pp. 723-727
Authors:
Smith, SL
Pruitt, CA
Sine, CS
Hudgins, AC
Stewart, WC
Citation: Sl. Smith et al., Latanoprost 0.005% and anterior segment uveitis, ACT OPHTH S, 77(6), 1999, pp. 668-672
Authors:
Konstas, AGP
Mantziris, DA
Maltezos, A
Cate, EA
Stewart, WC
Citation: Agp. Konstas et al., Comparison of 24 hour control with Timoptic (R) 0.5% and Timoptic-XE (TM) 0.5% in exfoliation and primary open-angle glaucoma, ACT OPHTH S, 77(5), 1999, pp. 541-543
Authors:
Smith, SL
Pruitt, CA
Sine, CS
Hudgins, AC
Stewart, WC
Citation: Sl. Smith et al., The use of latanoprost 0.005% once daily to simplify medical therapy in patients with primary open-angle glaucoma or ocular hypertension, ACT OPHTH S, 77(2), 1999, pp. 189-192
Authors:
Stewart, WC
Hudgins, AC
Pruitt, CA
Sine, C
Citation: Wc. Stewart et al., Daily cost of newer glaucoma agents, J OCUL PH T, 15(5), 1999, pp. 379-388
Authors:
Stewart, WC
Cate, EA
Stewart, JA
Citation: Wc. Stewart et al., Systemic beta-blockade with once daily Betimol (TM) or Timoptic-XE (TM), J OCUL PH T, 15(3), 1999, pp. 225-231
Authors:
Smith, SL
Sine, CS
Pruitt, CA
Stewart, WC
Citation: Sl. Smith et al., The use of latanoprost 0.005% once daily and its effect on intraocular pressure as primary or adjunctive therapy, J OCUL PH T, 15(1), 1999, pp. 29-39
Authors:
Konstas, AGP
Maltezos, A
Mantziris, DA
Sine, CS
Stewart, WC
Citation: Agp. Konstas et al., The comparative ocular hypotensive effect of apraclonidine with timolol maleate in exfoliation versus primary open-angle glaucoma patients, EYE, 13, 1999, pp. 314-318
Authors:
Stewart, WC
Morrison, RF
Young, SL
Stephens, JM
Citation: Wc. Stewart et al., Regulation of signal transducers and activators of transcription (STATs) by effectors of adipogenesis: coordinate regulation of STATs 1, 5A, and 5B with peroxisome proliferator-activated receptor-gamma and C/AAAT enhancer binding protein-alpha, BBA-MOL CEL, 1452(2), 1999, pp. 188-196
Authors:
Stewart, WC
Day, DG
Sharpe, ED
Dubiner, HB
Holmes, KT
Stewart, JA
Citation: Wc. Stewart et al., Efficacy and safety of timolol solution once daily vs timolol gel added tolatanoprost, AM J OPHTH, 128(6), 1999, pp. 692-696